Neoadjuvant camrelizumab combined with metronomic chemotherapy in patients with advanced esophageal squamous cell carcinoma: a pilot randomized phase 2 trial
Authors
Kaiyi Fu
Lung‐Chun Lin (ORCID: https://orcid.org/0000-0002-7325-0823)
Shiman Fu
Beibei Mao (ORCID: https://orcid.org/0000-0002-5889-4786)
Neoadjuvant camrelizumab combined with metronomic chemotherapy in patients with advanced esophageal squamous cell carcinoma: a pilot randomized phase 2 trial
Kaiyi Fu, Lung‐Chun Lin, Shiman Fu, Beibei Mao et al.
Journal
BMC Medicine
Topics
Esophageal Cancer Research and Treatment
article
Neoadjuvant camrelizumab combined with metronomic chemotherapy in patients with advanced esophageal squamous cell carcinoma: a pilot randomized phase 2 trial
Kaiyi Fu, Lung‐Chun Lin, Shiman Fu, Beibei Mao, W. Li, G. Chen, Shenyang Zhao, Hongyang Zhang, Zhiqiang Chen, Yang Song, Bin Lv, Jianxing Liu, Xia Guo, Wanwei Zheng, Ning Wu, Zhongguang Luo, Feifei Luo, Shaocong Mo, Yongjun Zhu, Jiayan Wu, Feng Tang, Jun Zhang, Yumeng Guo, Yao Liu, Kewei Ma, Yujen Tseng
article en
Abstract
No abstract available for this paper.
Publication Tag
BMC Medicine
Institutions
Fudan University (CN), Huashan Hospital (CN), Genecast (China) (CN)